Roberta Rudà

25PUBLICATIONS
179CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesLiquid biopsiesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

|Sep 16, 2025
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.

Roberta Rudà, Francesco Bruno, Alessia Pellerino

|Sep 02, 2025
Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures.

Riccardo Pascuzzo, Roberta Rudà, Peter B Barker

|Aug 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Chetan Bettegowda, Houtan Noushmehr, Alessandra Affinito

|Aug 12, 2025
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome.

Alessia Pellerino, Neibla Priego, Luca Bertero

|Aug 05, 2025
The concept, intention, and evaluation of the term treatment-refractory meningioma.

Lasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli

Pageof 5

Frequent Collaborators

11 joint publications

Riccardo Soffietti

8 joint publications

Alessia Pellerino

6 joint publications

Francesco Bruno

5 joint publications

Luca Bertero